IVF invobioscience.com: Forward P/S Multiple
INVO Fertility Inc (IVF) management is implementing advanced in vivo fetal incubation methods to provide affordable infertility treatment. The temporary trajectory on the GURU.Markets chart based on the forward P/S valuation confirms this vector, where 0.40 records a new level mark. The high cost of IVF provides the company with pricing power, while an ethical approach to reproduction fosters deep patient loyalty.
Metric breakdowns and analytics for INVO Fertility Corp (IVF)
- current price and projected stock value:
- company stock capitalization data:
- issuer book value statistics:
- company total debt and liquidity indicators:
- financial results and valuation multiples details:
IVF - Annual Net Income|Future Profit INVO Fertility Inc|IVF - P/E Multiple|Forward P/E Multiple INVO Bioscience, Inc.|IVF - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility Corp|IVF - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months INVO Fertility|IVF - Net earnings per share for the last 12 months|Quarterly EPS earnings growth invobioscience.com|IVF - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year INVO Fertility Inc
- sales volume and revenue indicators:
Summary company analytics:INVO Fertility (IVF)
Analyzing the ratio of market capitalization to expected sales is critical for selecting assets with a high margin of safety. This metric measures the premium paid for future growth, which, for the fabless model of INVO Fertility (IVF) utilizing outsourced incubator assembly, allows for an assessment of revenue scaling efficiency relative to business valuation by analyzing the forward price-to-sales multiple chart.
Key competitors
Forward P/S Multiple BSX (Boston Scientific Corporation)|Edwards (EW) - Market Cap to Future Revenue Ratio|ResMed Corp - Forward P/S Multiple|PODD (Insulet Inc.) - Market Cap to Projected Revenue|ZBH: Forward P/S Multiple|COO - Market Cap to Expected Sales Ratio|ALGN (Align Technology) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Globus Medical Inc (GMED)|Forward P/S Multiple TMDX|Forward P/S Multiple Alphatec Corp (ATEC)|Price-to-Projected Revenue Ratio Artivion, Inc. AORT|enovis.com - Price-to-Projected Revenue Ratio|IART: Forward Price-to-Revenue Multiple|Forward Price to Sales ESTA (Establishment Labs Corp)|BBNX: Forward P/S Multiple|Market Cap to Future Revenue Ratio IRADIMED Inc. (IRMD)|Price-to-Projected Revenue Ratio Embecta Corp.|TNDM - Projected Price to Revenue|Forward Price-to-Revenue Multiple AXGN (Axogen)|Forward P/S Multiple SI-BONE Inc (SIBN)|Forward P/S Multiple OFIX (Orthofix International)|Market Cap to Expected Sales Ratio Bioventus Global (BVS)|KIDS - Price-to-Projected Revenue Ratio|Future Price to Revenue TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Carlsmed, Inc.|RXST (RxSight Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio ClearPoint CLPT|Price-to-Projected Revenue Ratio Stereotaxis, Inc. (STXS)|neurostar.com - Market Cap to Projected Revenue|Sight Sciences - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio OBIO (Orchestra BioMed Inc.)|Anika - Forward P/S Multiple|Market Cap to Expected Sales Ratio InspireMD Inc. NSPR|zhjmedical.com (ZJYL) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue VANI|Forward Price-to-Revenue Multiple XTNT|Price-to-Projected Revenue Ratio NMTC|Price-to-Projected Revenue Ratio Modular Medical (MODD)|MYO - Market Cap to Future Revenue Ratio|Envoy Medical, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales VVOS|enVVeno Medical Corp. - Forward P/S Multiple|Future Price to Revenue SINT|TNON: Forward P/S Multiple|Market Cap to Future Revenue Ratio Lifeward Ltd. (LFWD)|Price-to-Projected Revenue Ratio Autonomix Medical Inc.|BBLG: Forward Price to Sales|Forward Price-to-Revenue Multiple AXNX (Axonics)|Price to Expected Revenue Ratio BIOL|Forward P/S Multiple DYNT (Dynatronics)|Market Cap to Expected Sales Ratio Paragon 28 Inc. (FNA)|INVO - Price-to-Projected Revenue Ratio
